Clinical Trials Browser

Phase 3 × SCLC × Topotecan × Clear all

NCT06616532 2024-12-19

PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer

Phase 3 Recruiting

SCLC